Ck Life Sciences
Ck Life Sciences, also known as Ck Life Sciences International Holdings, is a prominent biotechnology company headquartered in Hong Kong. Founded in 2000, the company has established itself as a leader in the life sciences sector, focusing on innovative solutions in agricultural biotechnology and healthcare. With a strong presence in Asia and expanding operations globally, Ck Life Sciences is dedicated to developing unique products that enhance crop yields and improve human health. Their core offerings include advanced biopesticides and nutraceuticals, distinguished by their commitment to sustainability and efficacy. Recognised for its pioneering research and development, Ck Life Sciences has achieved significant milestones, positioning itself as a key player in the biotechnology industry. The company continues to drive advancements that contribute to a healthier and more sustainable future.
DitchCarbon Score
How does Ck Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ck Life Sciences's score of 39 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ck Life Sciences's reported carbon emissions
Ck Life Sciences, headquartered in Hong Kong, has made significant strides in addressing its carbon emissions, with the most recent data indicating total emissions of approximately 48,960,000 kg CO2e for the year 2023. This figure comprises about 32,037,000 kg CO2e from Scope 1 emissions and about 16,923,000 kg CO2e from Scope 2 emissions. In 2022, the company reported total emissions of about 46,880,000 kg CO2e, showing a slight increase in 2023. Over the years, Ck Life Sciences has demonstrated a commitment to reducing its carbon footprint, with a long-term target to achieve net-zero emissions by 2050, as outlined in their sustainability report. This target encompasses all scopes of emissions, reflecting a comprehensive approach to climate action. The company has consistently disclosed its emissions data for Scope 1 and Scope 2, while it has not yet reported on Scope 3 emissions. Their emissions intensity has shown variability, with a reported intensity of approximately 0.0719 kg CO2e per unit of revenue in 2023. Ck Life Sciences continues to focus on sustainability initiatives and aims to align its operations with global climate goals, reinforcing its commitment to environmental stewardship.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 28,483,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,100,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ck Life Sciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
